Free Trial

Indivior (INDV) Competitors

Indivior logo
$16.08 +0.69 (+4.45%)
Closing price 07/3/2025 03:50 PM Eastern
Extended Trading
$15.26 -0.82 (-5.10%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INDV vs. ELAN, RVMD, LEGN, GRFS, TGTX, NUVL, LNTH, TLX, AXSM, and AKRO

Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), Lantheus (LNTH), Telix Pharmaceuticals (TLX), Axsome Therapeutics (AXSM), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry.

Indivior vs. Its Competitors

Elanco Animal Health (NYSE:ELAN) and Indivior (NASDAQ:INDV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 60.3% of Indivior shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Elanco Animal Health presently has a consensus target price of $15.33, suggesting a potential upside of 4.74%. Indivior has a consensus target price of $17.00, suggesting a potential upside of 5.69%. Given Indivior's stronger consensus rating and higher possible upside, analysts plainly believe Indivior is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elanco Animal Health
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Indivior
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Elanco Animal Health has a net margin of 8.43% compared to Indivior's net margin of -4.02%. Elanco Animal Health's return on equity of 7.54% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Elanco Animal Health8.43% 7.54% 3.57%
Indivior -4.02%-97.29%15.74%

In the previous week, Elanco Animal Health had 1 more articles in the media than Indivior. MarketBeat recorded 11 mentions for Elanco Animal Health and 10 mentions for Indivior. Elanco Animal Health's average media sentiment score of 0.55 beat Indivior's score of 0.50 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elanco Animal Health
1 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Indivior
2 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elanco Animal Health has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, Indivior has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.

Elanco Animal Health has higher revenue and earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elanco Animal Health$4.44B1.64$338M$0.7419.78
Indivior$1.19BN/A$2M-$0.31-51.89

Summary

Elanco Animal Health beats Indivior on 12 of the 16 factors compared between the two stocks.

Get Indivior News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INDV vs. The Competition

MetricIndiviorMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.43B$5.53B$9.02B
Dividend YieldN/A1.78%5.22%3.99%
P/E Ratio-51.899.1527.7520.25
Price / SalesN/A680.43438.76119.26
Price / Cash8.4721.7726.2128.59
Price / Book-6.384.558.025.65
Net Income$2M$31.26M$3.18B$249.15M
7 Day Performance9.12%2.98%2.88%2.91%
1 Month Performance14.32%3.46%1.67%4.11%
1 Year Performance6.52%0.77%34.26%20.98%

Indivior Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INDV
Indivior
2.0451 of 5 stars
$16.09
+4.4%
$17.00
+5.7%
+6.5%$0.00$1.19B-51.891,051High Trading Volume
ELAN
Elanco Animal Health
2.3831 of 5 stars
$14.29
flat
$15.17
+6.1%
+3.0%$7.10B$4.44B19.319,000Analyst Upgrade
RVMD
Revolution Medicines
4.5774 of 5 stars
$36.79
-0.3%
$67.58
+83.7%
-1.4%$6.88B$11.58M-9.20250
LEGN
Legend Biotech
3.0923 of 5 stars
$35.49
+2.5%
$76.20
+114.7%
-23.7%$6.36B$627.24M-60.152,609Positive News
GRFS
Grifols
4.1158 of 5 stars
$9.04
+2.0%
$10.30
+13.9%
+28.9%$6.09B$7.81B7.7323,822News Coverage
Analyst Upgrade
TGTX
TG Therapeutics
3.2906 of 5 stars
$35.99
-2.0%
$40.80
+13.4%
+95.7%$5.83B$329M149.96290
NUVL
Nuvalent
3.7239 of 5 stars
$76.30
-4.2%
$119.60
+56.7%
+10.3%$5.72BN/A-17.3840
LNTH
Lantheus
4.4551 of 5 stars
$81.86
+0.5%
$130.50
+59.4%
+0.4%$5.64B$1.53B23.26700Positive News
TLX
Telix Pharmaceuticals
N/A$16.07
+0.4%
$22.00
+36.9%
N/A$5.41B$516.72M0.00N/A
AXSM
Axsome Therapeutics
4.7484 of 5 stars
$104.39
+1.0%
$172.33
+65.1%
+28.5%$5.09B$385.69M-18.09380Trending News
AKRO
Akero Therapeutics
3.4504 of 5 stars
$53.36
-5.0%
$82.50
+54.6%
+142.5%$4.48BN/A-27.3630

Related Companies and Tools


This page (NASDAQ:INDV) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners